By Joanne Silberner With the release over the weekend of results from an investigation of a once-popular diabetes drug by the Senate Finance Committee, the new regime at the Food and Drug Administration has quite a mess on its hands. Avandia is getting
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/02/avandia_fda_heart_attacks.html?ft=1&f=103537970
Posted
Feb 22 2010, 01:12 PM
by
NPR Blogs: Shots - Health News